M&A & Special Situations

Learning objectives

By the end you can:

1. Classify any deal along the four axes that determine how you model it: strategic vs financial buyer, cash vs stock vs mixed consideration, asset vs stock (share) purchase, and friendly/negotiated vs hostile/tender. Explain how each axis changes the accounting, the tax, and the risk.
2. Build a sources-and-uses table from scratch, translating an offer price into an equity purchase price and an enterprise value, adding refinanced debt, transaction and financing fees, and minimum cash, then funding it with new debt, new equity, and cash on hand so that sources equal uses to the rupee.
3. Run a complete accretion/dilution analysis by hand for an all-stock, all-cash/debt, or mixed deal, computing the exchange ratio, pro-forma net income (net of after-tax financing cost), pro-forma share count, pro-forma EPS, and the accretion/dilution percentage. State the two "parity rules" that let you call the sign before you compute.
4. Separate accretion from value creation, quantify synergies with a present-value discipline (run-rate vs realized, phasing, cost-to-achieve, revenue vs cost), compute how much of the synergy value the acquirer pays away in the premium, and apply a skeptic's haircut that reflects the empirical record.
5. Analyze spin-offs, demergers, carve-outs and split-offs: explain the value-unlock logic, compute a sum-of-the-parts valuation and a when-issued "stub" value, work an entitlement ratio, and walk an Indian scheme of arrangement through NCLT under Sections 230–232 of the Companies Act, 2013.
6. Price a merger-arbitrage spread: gross spread, annualized return, market-implied completion probability, and a probability-weighted expected value against a defined break price. Explain why the arbitrageur's real product is a handicap on deal completion, not a view on value.
7. Read a fairness opinion with disciplined skepticism: name the banker conflicts (contingent/success fees, staple financing), the assumptions most often bent (terminal growth, discount rate, projections handed over by management), and the questions that turn a rubber-stamp into evidence.

Prerequisites & connections

Builds on. Phase 3 end-to-end: M3.01 (time value of money: every synergy PV and arb annualization is TVM), M3.03 (WACC and the cost of debt/equity you use to discount synergies and judge financing), M3.04–3.05 (DCF and owner earnings: what a target is worth before a premium), M3.06 (relative valuation/comps, whose EV/EBITDA multiples drive a sum-of-the-parts), M3.07 (capital allocation and the proxy, the record that tells you whether this management should be trusted to acquire), and M3.09 (the LBO: the financial buyer's model, and the leverage math a sources-and-uses table shares). From Phase 1: M1.07–M1.09 (goodwill, purchase accounting, and consolidation: what a deal does to the balance sheet). From Phase 2: M2.08 (quality of earnings: never model a target you have not QoE-cleared; a fabricated target is a fabricated synergy). From the Excel track: EX7.01 (professional modeling standards: the merger model is where the checks-and-flags row earns its keep). And the ethics/governance thread throughout, which peaks in M&A: a control transaction is the sharpest test of a board's fiduciary duty there is.

Feeds into. C5 (value a business three ways: the deal adds the control-premium and synergy layers), C7 (evaluate management and capital allocation: the M&A/buyback record is the highest-stakes evidence of allocation skill), C10 (the signature teardown: "is this company an acquirer, a target, or a break-up candidate?" belongs in every deep dive), and the sibling elective E11.01 (credit and covenants: the debt in your sources-and-uses lives or dies on the covenants E11.01 teaches you to read). E11.06 extends §4.5's spin-off work and §4.6's merger arbitrage into the rest of the event-driven set: rights offerings and the ex-rights price, the securities distributed in a deal that nobody wanted, the stub left standing after a recapitalisation, and the liquidation anchor.

The one-sentence version. A deal is a valuation with three extra moving parts bolted on: a control premium you pay for certain, synergies you hope to earn later, and a financing structure that decides who keeps the difference; the analyst's job is to keep those three honest while everyone in the room has an incentive to pretend the deal is better than it is.